FDA approves Artoss’ NanoBone SBX Putty

Foley, Minn.-based biotech Artoss recently earned market clearance from the Food and Drug Administration for NanoBone SBX Putty.

Advertisement

NanoBone SBX Putty is a synthetic bone replacement material intended to stimulate quicker bone formation, according to the NanoBone’s website.

Artoss plans to introduce the product to the U.S. market in the next few weeks.

More articles on supply chain:

5 trends on the growing role of digitization in supply chain
FDA approves expanded use of Janssen’s Darzalex for multiple myeloma patients
Texas Blood Center in desperate need of O-negative blood

 

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.